-
1
-
-
0018608356
-
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
-
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H , Caine, E. D , Reichertand, C. M., and Kopin, I. J. (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr. Res. 1, 249-254.
-
(1979)
Psychiatr. Res.
, vol.1
, pp. 249-254
-
-
Davis, G.C.1
Williams, A.C.2
Markey, S.P.3
Ebert, M.H.4
Caine, E.D.5
Reichertand, C.M.6
Kopin, I.J.7
-
2
-
-
0020680904
-
Chronic parkinsonism in humans due to a product of meperidine- analog synthesis
-
Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983) Chronic parkinsonism in humans due to a product of meperidine- analog synthesis. Science 219, 979-980.
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langston, J.W.1
Ballard, P.2
Tetrud, J.W.3
Irwin, I.4
-
3
-
-
0023224837
-
Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
-
Singer, T. P., Castagnoli, N., Jr., Ramsay, R. R., and Trevor, A. J. (1987) Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem. 49, 1-8.
-
(1987)
J Neurochem.
, vol.49
, pp. 1-8
-
-
Singer, T.P.1
Castagnoli Jr., N.2
Ramsay, R.R.3
Trevor, A.J.4
-
4
-
-
0025128332
-
The neurotoxicity of MPTP and relevance to parkinson's disease
-
McCrodden, J. M., Tipton, K. F., and Sullivan, J. P. (1990) The neurotoxicity of MPTP and relevance to parkinson's disease. Pharmacol. Toxicol. 67, 8-13.
-
(1990)
Pharmacol. Toxicol.
, vol.67
, pp. 8-13
-
-
McCrodden, J.M.1
Tipton, K.F.2
Sullivan, J.P.3
-
5
-
-
0025147290
-
The MPTP story: MAO activities tetrahydropyridine derivatives to toxins causing parkinsonism
-
Maret, G., Testa, B., Jenner, P., Tayar, N. E., and Carrupt, P.-A. (1990) The MPTP story: MAO activities tetrahydropyridine derivatives to toxins causing parkinsonism. Drug Metab. Rev. 22, 291-332.
-
(1990)
Drug Metab. Rev.
, vol.22
, pp. 291-332
-
-
Maret, G.1
Testa, B.2
Jenner, P.3
Tayar, N.E.4
Carrupt, P.-A.5
-
6
-
-
0021819789
-
Metabolism of the negrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions
-
Weissman, J., Trevor, A., Chiba, K., Peterson, L. A., Caldera, P., Castagnoli, N., Jr., and Baillie, T. (1985) Metabolism of the negrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions. J. Med. Chem. 28, 997-1001.
-
(1985)
J. Med. Chem.
, vol.28
, pp. 997-1001
-
-
Weissman, J.1
Trevor, A.2
Chiba, K.3
Peterson, L.A.4
Caldera, P.5
Castagnoli Jr., N.6
Baillie, T.7
-
7
-
-
0022634053
-
Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations
-
Cashman, J. R., and Ziegler, D. M. (1986) Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations. Mol. Pharmacol. 29, 163-169.
-
(1986)
Mol. Pharmacol.
, vol.29
, pp. 163-169
-
-
Cashman, J.R.1
Ziegler, D.M.2
-
8
-
-
0023687420
-
Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
-
Chiba, K., Kubota, E., Miyakawa, T., Kato, Y., and Ishizaki, T. (1988) Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J. Pharmacol. Exp. Ther. 246, 1108-1115.
-
(1988)
J. Pharmacol. Exp. Ther.
, vol.246
, pp. 1108-1115
-
-
Chiba, K.1
Kubota, E.2
Miyakawa, T.3
Kato, Y.4
Ishizaki, T.5
-
9
-
-
0023114660
-
Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytotoxicity in isolated hepatocytes
-
Smith, M. T., Ekstrom, G., Sandy, M. S., and Di Monte, D. (1987) Studies on the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine cytotoxicity in isolated hepatocytes. Life Sci. 40 741-748.
-
(1987)
Life Sci.
, vol.40
, pp. 741-748
-
-
Smith, M.T.1
Ekstrom, G.2
Sandy, M.S.3
Di Monte, D.4
-
10
-
-
0025134990
-
Studies on the cytochrome P-450 catalyzed ring α-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
-
Ottoboni, S., Carlson, T. J., Trager, W. F., Castagnoli, K., and Castagnoli, N., Jr. (1990) Studies on the cytochrome P-450 catalyzed ring α-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Chem. Res. Toxicol. 3, 423-427.
-
(1990)
Chem. Res. Toxicol.
, vol.3
, pp. 423-427
-
-
Ottoboni, S.1
Carlson, T.J.2
Trager, W.F.3
Castagnoli, K.4
Castagnoli Jr., N.5
-
11
-
-
0023899593
-
Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes
-
Monte, D. D., Shinka, T., Sandy, M. S., Castagnoli, N., Jr , and Smith, M. T. (1988) Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes. Drug Metab. Dispos. 16, 250-255.
-
(1988)
Drug Metab. Dispos.
, vol.16
, pp. 250-255
-
-
Monte, D.D.1
Shinka, T.2
Sandy, M.S.3
Castagnoli Jr., N.4
Smith, M.T.5
-
12
-
-
0026334303
-
Depletion of striatal dopamine by N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
-
Lau, Y.-S., Fung, Y. K., Trobough, K. L., Cashman, J. R., and Wilson, J. A. (1991) Depletion of striatal dopamine by N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurotoxicology 12, 189-200
-
(1991)
Neurotoxicology
, vol.12
, pp. 189-200
-
-
Lau, Y.-S.1
Fung, Y.K.2
Trobough, K.L.3
Cashman, J.R.4
Wilson, J.A.5
-
13
-
-
0023568113
-
MPTP, the neurotoxin inducing parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450buf1, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem
-
Fonne-Pfister, R., Bargetzi, M. J., and Meyer, U. A. (1987) MPTP, the neurotoxin inducing parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450buf1, P450db1) catalyzing debrisoquine 4-hydroxylation. Biochem. Biophys. Res. Commun. 148, 1144-1150.
-
(1987)
Biophys. Res. Commun.
, vol.148
, pp. 1144-1150
-
-
Fonne-Pfister, R.1
Bargetzi, M.J.2
Meyer, U.A.3
-
14
-
-
0023754383
-
Xenobiotic and endobiotic inhibitors of cytochrome P-450db1 function, the target of the debrisoquine/sparteine type polymorphism
-
Fonne-Pfister, R., and Meyer, U. A. (1988) Xenobiotic and endobiotic inhibitors of cytochrome P-450db1 function, the target of the debrisoquine/sparteine type polymorphism. Biochem. Pharmacol. 37, 3829-3835.
-
(1988)
Biochem. Pharmacol.
, vol.37
, pp. 3829-3835
-
-
Fonne-Pfister, R.1
Meyer, U.A.2
-
15
-
-
3142601993
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively depresses brain bufuralol hydroxylase activity in C57 BL/6J mice
-
Shahi, G. S., Das, N. P., Lee, E. J. D., and Moochhala, S. M. (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively depresses brain bufuralol hydroxylase activity in C57 BL/6J mice. Soc. Neurosci. Abstr. 14, 1217.
-
(1988)
Soc. Neurosci. Abstr.
, vol.14
, pp. 1217
-
-
Shahi, G.S.1
Das, N.P.2
Lee, E.J.D.3
Moochhala, S.M.4
-
16
-
-
0025087559
-
Parkinson's disease and cytochrome P450: A possible link?
-
Shahi, G. S., Das, N. P., and Moochhala, S. M. (1990) Parkinson's disease and cytochrome P450: A possible link? Med. Hypotheses 32, 277-282.
-
(1990)
Med. Hypotheses
, vol.32
, pp. 277-282
-
-
Shahi, G.S.1
Das, N.P.2
Moochhala, S.M.3
-
17
-
-
0022408175
-
Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine
-
Barbeau, A., Cloutier, T., Plasse, L., Roy, M., Paris, S., and Poirier, J. (1985) Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 2, 1213-1215.
-
(1985)
Lancet
, vol.2
, pp. 1213-1215
-
-
Barbeau, A.1
Cloutier, T.2
Plasse, L.3
Roy, M.4
Paris, S.5
Poirier, J.6
-
18
-
-
0026589459
-
Mutant debrisoquine hydroxylation genes in Parkinson's disease
-
Armstrong, M., Daly, A. K., Cholerton, S., Bateman, D. N., and Idle, J. R. (1992) Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 339, 1017-1018.
-
(1992)
Lancet
, vol.339
, pp. 1017-1018
-
-
Armstrong, M.1
Daly, A.K.2
Cholerton, S.3
Bateman, D.N.4
Idle, J.R.5
-
19
-
-
0027330416
-
Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease
-
Kurth, M. C., and Kurth, J. H. (1993) Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am. J. Med. Genet. 48, 166-168.
-
(1993)
Am. J. Med. Genet.
, vol.48
, pp. 166-168
-
-
Kurth, M.C.1
Kurth, J.H.2
-
20
-
-
78651165715
-
The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature
-
Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. J Biol. Chem. 239, 2370-2378.
-
(1964)
J Biol. Chem.
, vol.239
, pp. 2370-2378
-
-
Omura, T.1
Sato, R.2
-
21
-
-
0026639457
-
Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats
-
Suzuki, T., Narimatsu, S., Fujita, S., Masubuchi, Y., Umeda, S., Imaoka, S., and Funae, Y. (1992) Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats. Drug Metab. Dispos. 20, 367-373.
-
(1992)
Drug Metab. Dispos.
, vol.20
, pp. 367-373
-
-
Suzuki, T.1
Narimatsu, S.2
Fujita, S.3
Masubuchi, Y.4
Umeda, S.5
Imaoka, S.6
Funae, Y.7
-
22
-
-
0024310194
-
Evaluation of the involvement of a male specific cytochrome P-450 isozyme in senescence-associated decline of hepatic drug metabolism in male rats
-
Fujita, S., Morimoto, R., Chiba, M., Kitani, K., and Suzuki, T. (1989) Evaluation of the involvement of a male specific cytochrome P-450 isozyme in senescence-associated decline of hepatic drug metabolism in male rats. Biochem. Pharmacol. 38, 3925-3931
-
(1989)
Biochem. Pharmacol.
, vol.38
, pp. 3925-3931
-
-
Fujita, S.1
Morimoto, R.2
Chiba, M.3
Kitani, K.4
Suzuki, T.5
-
23
-
-
0017088267
-
Some properties of detergent-solubilized NADPH - Cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography
-
Yasukochi, Y., and Masters, B. S. S. (1976) Some properties of detergent-solubilized NADPH - cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251, 5337-5344.
-
(1976)
J. Biol. Chem.
, vol.251
, pp. 5337-5344
-
-
Yasukochi, Y.1
Masters, B.S.S.2
-
24
-
-
71849104860
-
Protein measurement with the Folin phenol reagent
-
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R J. (1951) Protein measurement with the Folin phenol reagent J. Biol. Chem. 193, 265-275.
-
(1951)
J. Biol. Chem.
, vol.193
, pp. 265-275
-
-
Lowry, O.H.1
Rosebrough, N.J.2
Farr, A.L.3
Randall, R.J.4
-
25
-
-
0019854279
-
A pharmacokinetic analysis program (MULTI) for microcomputer
-
Yamaoka, K., Tanigawara, Y., Nakagawa, T., and Uno, T. (1981) A pharmacokinetic analysis program (MULTI) for microcomputer J. Pharmacobio-Dyn. 4, 879-885.
-
(1981)
J. Pharmacobio-Dyn.
, vol.4
, pp. 879-885
-
-
Yamaoka, K.1
Tanigawara, Y.2
Nakagawa, T.3
Uno, T.4
-
26
-
-
0026031356
-
Impairment of debnsoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranolol
-
Masubuchi, Y., Fujita, S., Chiba, M., Kagimoto, N., Umeda, S., and Suzuki, T. (1991) Impairment of debnsoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranolol. Biochem. Pharmacol. 41, 861-865.
-
(1991)
Biochem. Pharmacol.
, vol.41
, pp. 861-865
-
-
Masubuchi, Y.1
Fujita, S.2
Chiba, M.3
Kagimoto, N.4
Umeda, S.5
Suzuki, T.6
-
27
-
-
0019492928
-
Animal modelling of human polymorphic drug oxidation - Metabolism of debrisoquine and phenacetin in rat inbred strains
-
Al-Dabbagh, S. G., Idle, J. R., and Smith, R L. (1981). Animal modelling of human polymorphic drug oxidation - metabolism of debrisoquine and phenacetin in rat inbred strains. J. Pharm Pharmacol. 33, 161-164.
-
(1981)
J. Pharm Pharmacol.
, vol.33
, pp. 161-164
-
-
Al-Dabbagh, S.G.1
Idle, J.R.2
Smith, R.L.3
-
28
-
-
0001786847
-
Enzymology of rat liver cytochrome P-450
-
(Guengerich, F. P., Ed.) CRC Press, Boca Raton, FL
-
Guengerich, F. P. (1987) Enzymology of rat liver cytochrome P-450. In Mammalian Cytochromes P-450 Vol. I, (Guengerich, F. P., Ed.) pp 1-54, CRC Press, Boca Raton, FL.
-
(1987)
Mammalian Cytochromes P-450
, vol.1
, pp. 1-54
-
-
Guengerich, F.P.1
-
29
-
-
0025990306
-
Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine
-
Jimenez-Jimenez, F. J., Tabernero, C., Mena, M. A., Yebenes, J. G., Yebenes, M. J. G., Casarejos, M. J., Pardo, B., Garcia-Agundez, J. A., Benitez, J., Martinez, A., and Garcia-Asenjo, J. A. L. (1991) Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine. J. Neurochem. 57, 81-87.
-
(1991)
J. Neurochem.
, vol.57
, pp. 81-87
-
-
Jimenez-Jimenez, F.J.1
Tabernero, C.2
Mena, M.A.3
Yebenes, J.G.4
Yebenes, M.J.G.5
Casarejos, M.J.6
Pardo, B.7
Garcia-Agundez, J.A.8
Benitez, J.9
Martinez, A.10
Garcia-Asenjo, J.A.L.11
-
30
-
-
0025779409
-
Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): Potent inhibition of activity by (-)- cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6
-
Tyndale, R. F., Sunahara, R., Inaba, T., Kalow, W., Gonzalez, F. J., and Niznik, H. B. (1991) Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)- cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Mol. Pharmacol. 40, 63-68.
-
(1991)
Mol. Pharmacol.
, vol.40
, pp. 63-68
-
-
Tyndale, R.F.1
Sunahara, R.2
Inaba, T.3
Kalow, W.4
Gonzalez, F.J.5
Niznik, H.B.6
-
31
-
-
0027515851
-
A novel P450 expressed at the high level in rat brain
-
Komori, M. (1993) A novel P450 expressed at the high level in rat brain. Biochem. Biophys. Res. Commun. 196, 721-728.
-
(1993)
Biochem. Biophys. Res. Commun.
, vol.196
, pp. 721-728
-
-
Komori, M.1
-
32
-
-
0026512229
-
Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes
-
Suzuki, T., Fujita, S., Narimatsu, S., Masubuchi, Y., Tachibana M., Ohta, S., and Hirobe, M. (1992) Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes. FASEB J. 6, 771-776.
-
(1992)
FASEB J.
, vol.6
, pp. 771-776
-
-
Suzuki, T.1
Fujita, S.2
Narimatsu, S.3
Masubuchi, Y.4
Tachibana, M.5
Ohta, S.6
Hirobe, M.7
-
33
-
-
0022428947
-
Predicting Parkinson's disease
-
Snyder, S. H , and D'Amato, R. J. (1985) Predicting Parkinson's disease. Nature 317, 198-199.
-
(1985)
Nature
, vol.317
, pp. 198-199
-
-
Snyder, S.H.1
D'Amato, R.J.2
|